Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169776 · ClinicalTrials.gov registry record · NA
Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04169776 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 7 participants.
The verdict
NCT04169776, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study evaluates the impact of transcutaneous auricular Vagus Nerve stimulation (taVNS) therapy on the incidence of nephrotic syndrome relapses in children with idiopathic nephrotic syndrome. Participants will perform taVNS 5 minutes a day for 6 months total, monitoring for signs of nephrotic syndrome relapse with both labwork and clinical symptoms.
Interventions
- DEVICE Transcutaneous Auricular Vagus Nerve (taVNS) stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04169776
The ClinicalTrials.gov registry entry for NCT04169776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Auricular Vagus Nerve (taVNS) stimulation is the first listed.
NCT04169776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04169776 about?
NCT04169776 is a clinical study titled "Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome". This study evaluates the impact of transcutaneous auricular Vagus Nerve stimulation (taVNS) therapy on the incidence of nephrotic syndrome relapses in children with idiopathic nephrotic syndrome. Participants will perform taVNS 5 minutes a day for 6 months total, monitoring for signs of nephrotic sy...
What is the current status of trial NCT04169776?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2019-12-01. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04169776?
The interventions under investigation include: Transcutaneous Auricular Vagus Nerve (taVNS) stimulation (DEVICE).
Who is sponsoring clinical trial NCT04169776?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.